Literature DB >> 17083759

DAS remission cut points.

J Fransen1, P L C M van Riel.   

Abstract

The Disease Activity Score (DAS) and DAS28 are continuous measures of rheumatoid arthritis (RA) disease activity. Values of DAS %lt;1.6 and DAS28 %lt; 2.6 correspond with an increased likelihood of being in remission. This review presents development of the DAS and DAS28 remission cut points and their interpretation.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17083759

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


  18 in total

1.  Rheumatoid arthritis: 2011 remission criteria are a new benchmark for RA therapy.

Authors:  Vivian P Bykerk
Journal:  Nat Rev Rheumatol       Date:  2011-05-10       Impact factor: 20.543

Review 2.  Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice.

Authors:  Jaclyn Anderson; Liron Caplan; Jinoos Yazdany; Mark L Robbins; Tuhina Neogi; Kaleb Michaud; Kenneth G Saag; James R O'Dell; Salahuddin Kazi
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-05       Impact factor: 4.794

3.  Discordance between clinical and imaging criteria: assessment by magnetic resonance imaging of the foot of patients with rheumatoid arthritis.

Authors:  Ronaldo Garcia Rondina; Ricardo Andrade Fernandes de Mello; Valeria Valim; Rafael Burgomeister Lourenco; Elton Francisco Pavan Batista; Ronaldo de Oliveira Júnior
Journal:  Rheumatol Int       Date:  2017-05-27       Impact factor: 2.631

4.  Calprotectin in rheumatoid arthritis : association with disease activity in a cross-sectional and a longitudinal cohort.

Authors:  Miriam García-Arias; Dora Pascual-Salcedo; Susana Ramiro; Marie-Eve Ueberschlag; Thomas M Jermann; Carlos Cara; Emilio Martín-Mola; Alejandro Balsa
Journal:  Mol Diagn Ther       Date:  2013-02       Impact factor: 4.074

5.  Evaluation of disease activity in rheumatoid arthritis by Routine Assessment of Patient Index Data 3 (RAPID3) and its correlation to Disease Activity Score 28 (DAS28) and Clinical Disease Activity Index (CDAI): an Indian experience.

Authors:  H Singh; V Gupta; S Ray; H Kumar; P Talapatra; M Kaur; S Kumar; S Arya; R Mathur; N Ghangas
Journal:  Clin Rheumatol       Date:  2012-09-15       Impact factor: 2.980

6.  Levels of anti-citrullinated protein antibodies and IgM rheumatoid factor are not associated with outcome in early arthritis patients: a cohort study.

Authors:  Jennie Ursum; Wouter H Bos; Nancy van Dillen; Ben Ac Dijkmans; Dirkjan van Schaardenburg
Journal:  Arthritis Res Ther       Date:  2010-01-12       Impact factor: 5.156

7.  Foot function in rheumatoid arthritis patients: a cross-sectional study.

Authors:  Agnes Patricia de Andrade; Elinah Narumi Inoue; Renato Nisihara; Thelma Larocca Skare
Journal:  Clin Rheumatol       Date:  2018-07-14       Impact factor: 2.980

8.  Is the Alifax Test-1TH useful to determine the Disease Activity Score (DAS28) in rheumatoid arthritis patients?

Authors:  M Levitus; A Pelliccia; R J van de Stadt; A E Voskuyl; A A Bouman
Journal:  Clin Rheumatol       Date:  2009-01-23       Impact factor: 2.980

9.  Optimizing Rheumatoid Arthritis Therapy: Using Objective Measures of Disease Activity to Guide Treatment.

Authors:  Gary M Owens
Journal:  Am Health Drug Benefits       Date:  2015-10

10.  Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study.

Authors:  Yvonne C Lee; Jing Cui; Bing Lu; Michelle L Frits; Christine K Iannaccone; Nancy A Shadick; Michael E Weinblatt; Daniel H Solomon
Journal:  Arthritis Res Ther       Date:  2011-06-08       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.